• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astal Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4277.0
  • ISIN : INE307N01014
94.30 3 (3.09%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    91.40

  • Today’s High

    95.00

  • Open

    91.50

  • Perv Close

    91.47

  • 52W Low

    66.72

  • 52W High

    131.70

Key Indicators

  • P/E(TTM)

    18.64

  • Mar.Cap (₹Cr.)

    166.34

  • Div & Yield %

    0.00

  • Book Value(₹)

    24.82

  • Debt-Equity Ratio

    3.09

  • AGM Date

    25-Jul-2025

  • EPS

    5.06

  • P/E Ratio

    18.64

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    166.34

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    17.64

  • BV (₹)

    24.80

  • Sales( ₹ in Cr.)

    64.23

  • NP (in Cr.)

    8.93

  • NP Var(%)

    1037.0

  • Div%

    0.0

  • CPS (₹)

    5.20

  • EPS (₹)

    5.10

  • Traded Value (₹ in Lakhs)

    166.34

  • 52 Week High

    131.70

  • 52 Week Low

    66.72

  • Price BSE

    94.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    166.34

  • P/C Ratio

    18.10

  • P/E Ratio

    18.60

  • Price Vs.BV

    5.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 23.65 3.43 0.00 0.20 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 23.65 3.43 0.00 0.20 0.00 0.00
Other Income 0.01 0.18 0.21 0.00 0.20 0.30
Stock Adjustments 1.06 0.00 0.00 0.00 0.00 0.00
Total Income 24.72 3.61 0.21 0.20 0.20 0.30
EXPENDITURE :            
Raw Materials 22.40 3.35 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.02 0.01 0.02 0.01 0.02 0.02
Employee Cost 0.47 0.06 0.09 0.06 0.09 0.07
Other Manufacturing Expenses 0.01 0.01 0.01 0.01 0.01 0.01
Selling and Administration Expenses 0.70 0.13 0.10 0.10 0.10 0.16
Miscellaneous Expenses 0.00 0.00 0.01 0.00 0.00 0.10
Employee Benefit Expenses 0.47 0.06 0.09 0.06 0.09 0.07
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 23.59 3.56 0.21 0.18 0.22 0.36
Operating Profit 1.13 0.04 0.00 0.02 -0.01 -0.06
Interest 0.01 0.00 0.00 0.00 0.00 0.00
Gross Profit 1.12 0.04 0.00 0.02 -0.01 -0.06
Depreciation 0.03 0.01 0.01 0.02 0.02 0.02
Profit Before Tax 1.09 0.03 -0.01 0.00 -0.03 -0.08
Current Tax 0.29 0.01 0.00 0.00 0.00 0.01
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.01 0.01 0.00 0.00 0.00 0.00
Reported Net Profit 0.78 0.02 -0.02 0.01 -0.03 -0.08
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.78 0.02 -0.02 0.01 -0.03 -0.08
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.99 0.98 0.99 0.99 1.02 1.10
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 1.78 0.99 0.98 0.99 0.99 1.02
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.80 0.04 -0.04 0.02 -0.07 0.00
Earnings Per Share(Adj)-Unit Curr 0.80 0.04 -0.04 0.02 - -
Book Value 23.71 12.98 12.93 12.97 12.96 13.03
Book Value(Adj)-Unit Curr 23.71 12.98 12.93 12.97 - -

Shareholding Pattern

  • Promoter Group

    19.93%

  • Public Share Holding

    80.07%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 1,959,284 19.93 1,959,284 1
Sub Total 1,959,284 19.93 1,959,284 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 548,351 5.58 511,151 31
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 20,297 0.21 20,297 14
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 85,255 0.87 85,255 39
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,103,637 51.92 5,103,637 71
Individuals holding nominal share capital up to Rs. 1 lakh 2,113,246 21.50 1,732,626 2,565
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,870,786 80.07 7,452,966 2,720
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,830,070 100.00 9,412,250 2,721

Company Background

Astal Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Astal Laboratories Ltd
  • BSE Code : 4277.0
  • ISIN : INE307N01014

  • Incorporation Year

    1993

  • Registered Office

    House No 4-50/1 Sy No 134 132
    Block B 8th Floor Flat No 801, Hyderabad,
    Telangana-500032

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    MAHENDRA KUMAR

  • Auditor

    Sathuluri & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.&Computer Ser.P Ltd
    Beetal House 3rd Flr,
    Behind Local Shp Cen,Nr Dada Harsukh Das
    Mumbai - New Delhi - 110062

Astal Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astal Lab 94.30 23.66 23.65 18.64 7.56
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10